Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Steroids Plus CO2 Laser for Vulvovaginal Lichen Sclerosus
NCT05243563Phase 3Terminated
- Sponsor
- University of South Alabama
- Start
- Apr 2022
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in vulvar lichen sclerosus (LS), sponsored by University of South Alabama. Primary endpoint: Skindex-29 at 6 months. Started Apr 2022; status: terminated.
02
Conditions
vulvar lichen sclerosus (LS)
Beyond the preview
Go deeper on NCT05243563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05243563.